Gelonghui October 18th, impulse(qingdao)health tech (002899.SZ) announced that the company (Party A) entered into an Investment Intention Agreement with Ru Yi (Party B1), Anji Liweike Enterprise Management Partnership Enterprise (limited partnership) (Party B2), Hangzhou Liweike Enterprise Management Partnership Enterprise (limited partnership) (Party B3) (hereinafter referred to as Party B), Hangzhou Liweike Technology Co., Ltd. (hereinafter referred to as Liweike Technology or the target company). The company plans to invest RMB 10 million in Liweike Technology through capital increase and share expansion.

Based on the company's global strategy layout and business development direction, the above private equity investment can further enrich the company's industrial layout, seek new revenue growth points for the company, enhance the overall competitiveness of the company, and drive the company's sustainable development.